Marc Casper has been president and chief executive officer of Thermo Fisher Scientific since October 2009. He was also elected chairman of the board in February 2020.

Mr. Casper joined Thermo Electron Corporation in 2001 as president of the Life Sciences sector. He was named senior vice president in 2003, and in 2005 assumed responsibility for all of the company’s operating divisions. After the merger that created Thermo Fisher Scientific in 2006, Mr. Casper was named executive vice president and president of its Analytical Technologies businesses, and in 2008 he became the company’s Chief Operating Officer.

Prior to joining Thermo Fisher, Mr. Casper served as president, chief executive officer and a director of Kendro Laboratory Products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as president–Americas. Mr. Casper began his career as a strategy consultant at Bain & Company and later joined Bain Capital.

Mr. Casper serves on the boards of U.S. Bancorp, U.S. China Business Council, Brigham & Women’s Hospital and Wesleyan University. He was previously a director of the Advisory Board Company and Zimmer Holdings. Mr. Casper earned an MBA with high distinction from Harvard Business School and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics.

Lisa joined the company in March 2017 as Senior Vice President and Chief Human Resources Officer, responsible for leading our global Human Resources strategy and operations.

She joined Thermo Fisher after six years with Nexeo Solutions, a Texas-based global leader in the distribution of plastics and chemicals, where she served as Executive Vice President and Chief Human Resources Officer. Prior to Nexeo, Lisa worked for Covidien, a $10 billion global leader in healthcare products. During her 13-year tenure, she served in a number of HR senior leadership roles, most recently as Vice President, Global Human Resources.

Lisa received her bachelor of arts degree from Lander University in Greenwood, South Carolina.

Greg joined the company in January 2002 as President, Environmental Instruments. He was named President, Scientific Instruments, in May 2006 and became Senior Vice President and President, Analytical Instruments, two years later. In 2012, Greg was named President, Biosciences, and in January 2014, he became Senior Vice President and President of the company’s Customer Channels business.

Prior to joining Thermo Fisher, Greg spent 14 years at General Electric, including two years at Borg Warner Chemicals (acquired by GE Plastics). While at GE, his career progressed through multiple sales, marketing and general management roles within the Plastics and Transportation Systems divisions.

Greg holds an MBA from Harvard Business School and bachelor’s degrees in chemical engineering from Virginia Tech and the University of Exeter.

Karen is responsible for the company’s corporate public relations, government relations, employee communications and multi-media functions, as well as executive, change management, crisis and investor communications.

She first joined the company when it was Thermo Electron Corporation and spent nearly 16 years in corporate communications and investor relations positions of increasing responsibility. In 1997, she was named Director of Corporate Communications, leading the function for the parent company and its 22 public subsidiaries. She developed and executed the communications strategy during the major reorganization in 2000 that re-focused the company and created a foundation for future growth.

In 2001, Karen left the company for five years to run a communications consultancy, serving a number of public-company clients, including Thermo Electron. She rejoined in her current role in 2006, at the time of the merger that created Thermo Fisher Scientific, and built the corporate communications function.

Karen earned a Bachelor of Science degree in journalism from Ohio University and began her career in advertising and public relations agencies in the Midwest. She is a member of the International Association of Business Communicators and the Communications 50, a group of communications leaders from major companies.

Michel was named Executive Vice President in September 2019, with responsibility for Thermo Fisher’s pharma services and customer channels businesses, as well as the company’s corporate accounts function. He joined the company as President, Pharma Services, through the acquisition of Patheon in 2017.

Michel previously served as President and Chief Operating officer of Patheon from 2016 to 2017, and prior to that, he was Managing Director at JLL Partners, a leading middle-market private equity firm focused on healthcare. At JLL, Michel worked with several of the organization’s portfolio companies, including Patheon, where he helped the executive committee transform the company into a global provider of biopharma development and commercial manufacturing services.

Before joining JLL, Michel was Chief Executive Officer and Chief Financial Officer (CFO) of the Domestic Appliances and Personal Care division of Philips Electronics North America. He also previously served as CFO of Philips Electronics in Indonesia and Financial Controller of Philips Electronics Hong Kong.

Michel earned a bachelor’s degree in business administration from European University in Antwerp and an executive master’s degree in finance and control from the University of Maastricht and University of Amsterdam.

Paul Parker was named Senior Vice President of Strategy and Corporate Development in April 2020, with responsibility for corporate strategy, mergers and acquisitions, and other corporate development opportunities.

Paul has more than 30 years of M&A banking experience in multiple sectors and geographies. Prior to joining Thermo Fisher, Paul served as Co-Chairman of the Global Mergers and Acquisitions Group in the Investment Banking Division for Goldman Sachs & Co. He also served on the firm's Partnership Committee and on the Investment Banking Senior Leadership Council. Prior to Goldman Sachs, Paul worked as Chairman and Head of Global M&A at both Barclays and Lehman Brothers. He served on the Executive Committee for the Investment Banking Division of both companies and on the Americas Management Committee for Barclays Group.

Paul earned an MBA with distinction from Harvard Business School and a bachelor's degree in international studies from the University of North Carolina at Chapel Hill.

Mike became Senior Vice President and President, Pharma Services, in October 2019. He joined Thermo Fisher in 2009 as Vice President and General Manager of China and was named President of China in 2012. In 2015, Mike was appointed President of the Chemical Analysis business, and in 2016, following the acquisition of FEI Company, he became President, Materials and Structural Analysis.

Prior to joining Thermo Fisher, Mike worked at 3M Company for more than 15 years, managing various industrial and electronics businesses. With 3M, he spent seven years in the Asia-Pacific region, serving as APAC Business Director for the company’s Industrial & Transportation Businesses as well as APAC Electronics Market Materials Division Manager.

Mike earned his Bachelor of Arts degree from the University of Minnesota.

Peter joined the company in 2014 as President, Biosciences, following the acquisition of Life Technologies and led the successful integration of the company’s biosciences businesses. He served in that role for three years before being named Senior Vice President and President, Life Sciences Solutions, in 2017. In this role, he leads our Biosciences, Genetic Sciences and Clinical Next-Generation Sequencing businesses, as well as several functions within Life Sciences Solutions.

Before joining Thermo Fisher, Peter served as President of Europe, Middle East and Africa for Life Technologies. In that role, he led the region through the integration of Invitrogen and Applied Biosystems and focused the team on developing emerging markets in Russia, South Africa and the Middle East. He has more than 20 years of experience in the life sciences industry, serving in a number of manufacturing, general management and commercial leadership roles around the world.

Peter holds a First Class Honors Degree in applied biology from the University of Hertfordshire in England.

Richard Spoor joined Thermo Fisher in April 2017 as Senior Vice President of Global Business Services.

Prior to joining our company, Richard served since June 2014 as Global Head of Product Supply for Bayer Consumer Health, after leading global procurement for Bayer Healthcare for three years. From 2005 to 2011, he was with Merck & Co., serving most recently as Senior Vice President of Global Procurement. Earlier in his career, Richard held various business, procurement and operational leadership positions at leading companies, including Nokia, QP Group and GE Lighting, with responsibilities in the Americas, Asia-Pacific region and Europe.

Richard received a bachelor’s degree with honors in industrial management from Nottingham Trent University in Nottingham, England. He is a fellow of the Chartered Institute of Purchasing and Supply.

In August 2015, Stephen was named Senior Vice President and Chief Financial Officer, responsible for the company’s tax, treasury, financial reporting and investor relations functions. He joined the company in 2001 as Vice President, European Financial Operations, based in the U.K., and oversaw the company’s integration activities across Europe. In 2004, Stephen moved to the U.S. and held finance leadership roles for a number of the company’s operating businesses. In 2008, he became Vice President of Financial Operations for Thermo Fisher Scientific and led the finance support function for all of the company’s businesses.

Stephen joined Thermo Fisher from Honeywell International (formerly AlliedSignal), where he served as Vice President and Chief Financial Officer, Asia-Pacific, in Singapore and held other finance roles in corporate development and operational finance. He began his career with Price Waterhouse in the transaction support group and the audit practice, working in both London and New York.

Stephen holds a bachelor's degree in accounting and finance from the University of Wales and is a member of the Institute of Chartered Accountants of England and Wales. Stephen serves on the board of International Flavors and Fragrances Inc.